GoodRx Holdings, Inc. (GDRX)Healthcare | Health Information Services | Santa Monica, United States | NasdaqGS
3.53 USD
+0.02
(0.570%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 3.53 |
Hot Take ↕ | Aug. 22, 2026, 5:38 a.m. EDT
The investment case for GoodRx is currently broken by a severe multi-year structural decline. Despite the company showing a forward P/E of roughly 9.7x and maintaining healthy gross margins, the stock has lost approximately 87% of its value over the last four years. The most recent annual return was a crushing -39.7%, marking the second consecutive year of significant losses. This persistent downward trajectory suggests the market has permanently downgraded the business's growth prospects, rendering the current low valuation a reflection of poor quality rather than a bargain. With no dividend to provide income and a balance sheet carrying debt nearly double its cash reserves, there is no safety net. While the forward P/E looks attractive on paper, it ignores the reality that the company is failing to grow revenue or earnings consistently. The options market confirms this pessimism, with traders buying heavy insurance against further drops while waiting for a miracle rally. Until the multi-year decline stops and turns into a sustained recovery, this remains a weak hold with deteriorating fundamentals. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.069685 |
| MSTL | 0.076921 |
| AutoETS | 0.079927 |
| AutoARIMA | 0.143908 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 0.70 |
| Ljung-Box p | 0.001 |
| Jarque-Bera p | 0.017 |
| Excess Kurtosis | 1.18 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 83.223 |
| Revenue per Share | 2.294 |
| Market Cap | 1,204,243,200 |
| Trailing P/E | 58.83 |
| Forward P/E | 9.91 |
| Beta | 1.58 |
| Profit Margins | 2.07% |
| Website | https://www.goodrx.com |
As of Aug. 22, 2026, 5:38 a.m. EDT: Speculators are heavily positioning for downside protection, evidenced by massive open interest in out-of-the-money puts (strikes $1.50-$2.00) compared to negligible put volume. Conversely, call activity is concentrated in deep out-of-the-money strikes ($5.00-$10.00), suggesting a speculative bet on a significant recovery rather than a near-term catalyst. The implied volatility skew shows significantly higher premiums for downside protection, indicating the market prices in a high probability of further decline.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.17906976 |
| Address1 | 2,701 Olympic Boulevard |
| All Time High | 64.219 |
| All Time Low | 1.77 |
| Ask | 4.49 |
| Ask Size | 2 |
| Average Analyst Rating | 2.5 - Hold |
| Average Daily Volume10 Day | 1,848,560 |
| Average Daily Volume3 Month | 1,430,574 |
| Average Volume | 1,430,574 |
| Average Volume10Days | 1,848,560 |
| Beta | 1.58 |
| Bid | 2.58 |
| Bid Size | 2 |
| Book Value | 1.904 |
| City | Santa Monica |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.53 |
| Current Ratio | 1.381 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 3.595 |
| Day Low | 3.5 |
| Debt To Equity | 83.223 |
| Display Name | GoodRx |
| Earnings Call Timestamp End | 1,786,017,600 |
| Earnings Call Timestamp Start | 1,786,017,600 |
| Earnings Growth | -0.445 |
| Earnings Quarterly Growth | -0.335 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,793,736,000 |
| Earnings Timestamp Start | 1,793,736,000 |
| Ebitda | 108,776,000 |
| Ebitda Margins | 0.13853 |
| Enterprise To Ebitda | 13.303 |
| Enterprise To Revenue | 1.843 |
| Enterprise Value | 1,447,080,192 |
| Eps Current Year | 0.30382 |
| Eps Forward | 0.35638 |
| Eps Trailing Twelve Months | 0.06 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.2013 |
| Fifty Day Average Change | 0.32870007 |
| Fifty Day Average Change Percent | 0.10267706 |
| Fifty Two Week Change Percent | -17.906975 |
| Fifty Two Week High | 5.81 |
| Fifty Two Week High Change | -2.28 |
| Fifty Two Week High Change Percent | -0.39242685 |
| Fifty Two Week Low | 1.77 |
| Fifty Two Week Low Change | 1.76 |
| Fifty Two Week Low Change Percent | 0.9943503 |
| Fifty Two Week Range | 1.77 - 5.81 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,600,867,800,000 |
| Float Shares | 92,399,228 |
| Forward Eps | 0.35638 |
| Forward P E | 9.905158 |
| Free Cashflow | 112,499,128 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 697 |
| Fullday Change | 0.02 |
| Fullday Change Percent | 0.5698 |
| Fullday Price | 3.53 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.90826 |
| Gross Profits | 713,192,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.12696 |
| Held Percent Institutions | 0.55939996 |
| Implied Shares Outstanding | 341,145,388 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Ipo Expected Date | 2,020-09-23 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. |
| Long Name | GoodRx Holdings, Inc. |
| Market | us_market |
| Market Cap | 1,204,243,200 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_576807508 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 16,249,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,197,420,311 |
| Number Of Analyst Opinions | 13 |
| Open | 3.5 |
| Operating Cashflow | 201,580,992 |
| Operating Margins | 0.11792 |
| Payout Ratio | 0.0 |
| Phone | 855 268 2822 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 3.53 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 3.51 |
| Price Eps Current Year | 11.618721 |
| Price Hint | 4 |
| Price To Book | 1.8539915 |
| Price To Sales Trailing12 Months | 1.5336185 |
| Profit Margins | 0.02069 |
| Quick Ratio | 0.423 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 2.53333 |
| Region | US |
| Regular Market Change | 0.02 |
| Regular Market Change Percent | 0.5698 |
| Regular Market Day High | 3.595 |
| Regular Market Day Low | 3.5 |
| Regular Market Day Range | 3.5 - 3.595 |
| Regular Market Open | 3.5 |
| Regular Market Previous Close | 3.51 |
| Regular Market Price | 3.53 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 1,001,592 |
| Return On Assets | 0.03046 |
| Return On Equity | 0.025179999 |
| Revenue Growth | -0.013 |
| Revenue Per Share | 2.294 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 107,181,201 |
| Shares Percent Shares Out | 0.0149 |
| Shares Short | 5,091,728 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 6,456,157 |
| Short Name | GoodRx Holdings, Inc. |
| Short Percent Of Float | 0.0531 |
| Short Ratio | 3.43 |
| Source Interval | 15 |
| State | CA |
| Symbol | GDRX |
| Target High Price | 5.0 |
| Target Low Price | 2.65 |
| Target Mean Price | 4.03077 |
| Target Median Price | 4.0 |
| Total Cash | 296,112,992 |
| Total Cash Per Share | 0.868 |
| Total Debt | 538,950,016 |
| Total Revenue | 785,230,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.06 |
| Trailing P E | 58.833336 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.680775 |
| Two Hundred Day Average Change | 0.84922504 |
| Two Hundred Day Average Change Percent | 0.31678343 |
| Type Disp | Equity |
| Volume | 1,001,592 |
| Website | https://www.goodrx.com |
| Zip | 90,404 |